Latest filing published 20 Mar 2017 for Syneron Medical Ltd., €792k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
North Tide Capital, LLC: trading record in brief
Filings by North Tide Capital, LLC span 6 companies, the busiest being Vivus Inc, Almost Family Inc and Select Medical Holdings Corp. We count 156 filings; the first trade dates from 17 December 2013 and the latest from 10 March 2017.
On the open market, the record shows 69 purchases worth €21.6M and 85 sales worth €57.0M. On balance, insiders were net sellers of €35.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2017 alone, the filings show no purchases and 39 sales.
The median purchase comes to €163k. The 14 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The record was last updated on 20 March 2017 with an open-market sale (€792k) in Syneron Medical Ltd. The last purchase on record was published on 5 April 2016, which is 3,869 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to North Tide Capital, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 81,500 shares@ US$10.27521.0% of flowCommon StockSEC:0001140361-17-012725:0
- 34,000 shares@ US$10.308.8% of flowCommon StockSEC:0001140361-17-012725:1
- 50,000 shares@ US$1.251.3% of flowCommon StockSEC:0001140361-17-011657:1
- 435,300 shares@ US$1.206611.1% of flowCommon StockSEC:0001140361-17-011657:2
- 237,100 shares@ US$1.20426.0% of flowCommon StockSEC:0001140361-17-011657:3
- 77,000 shares@ US$1.1721.9% of flowCommon StockSEC:0001140361-17-011657:4
- 350,000 shares@ US$1.05247.8% of flowCommon StockSEC:0001140361-17-011657:0
- 1,700 shares@ US$1.110.0% of flowCommon StockSEC:0001140361-17-010912:0
- 31,200 shares@ US$1.1050.7% of flowCommon StockSEC:0001140361-17-010912:1
- 10,000 shares@ US$1.0950.2% of flowCommon StockSEC:0001140361-17-010912:2
- 4,800 shares@ US$1.100.1% of flowCommon StockSEC:0001140361-17-010912:3
- 105,100 shares@ US$1.07472.4% of flowCommon StockSEC:0001140361-17-010912:4
- 40,000 shares@ US$1.080.9% of flowCommon StockSEC:0001140361-17-010912:5
- 25,500 shares@ US$1.12130.6% of flowCommon StockSEC:0001140361-17-010314:0
- 72,600 shares@ US$1.13651.7% of flowCommon StockSEC:0001140361-17-010314:1
- 42,000 shares@ US$1.13181.0% of flowCommon StockSEC:0001140361-17-010314:2
- 20,000 shares@ US$1.1250.5% of flowCommon StockSEC:0001140361-17-010314:3
- 150,000 shares@ US$1.16013.7% of flowCommon StockSEC:0001140361-17-009476:0
- 33,000 shares@ US$1.13650.8% of flowCommon StockSEC:0001140361-17-009476:1
- 107,000 shares@ US$1.1252.5% of flowCommon StockSEC:0001140361-17-009476:2
- 43,000 shares@ US$1.131.0% of flowCommon StockSEC:0001140361-17-009476:3
- 300 shares@ US$1.11170.0% of flowCommon StockSEC:0001140361-17-008656:0
- 52,164 shares@ US$1.10441.2% of flowCommon StockSEC:0001140361-17-008656:1
- 109,336 shares@ US$1.1122.6% of flowCommon StockSEC:0001140361-17-008656:2
- 115,000 shares@ US$1.102.7% of flowCommon StockSEC:0001140361-17-007988:0
25 of 153 declarations
